Noble (NE) Q1 2025 Earnings Call Transcript

Noble reported Q1 adjusted EBITDA of $338 million on $832 million of revenue and reiterated full-year 2025 guidance of $3.25 billion-$3.45 billion revenue and $1.05 billion-$1.15 billion adjusted EBITDA. Backlog jumped 30% quarter over quarter to $7.5 billion, driven by new Shell and TotalEnergies contracts totaling nearly 14 rig years and up to $2.5 billion of potential revenue, while the company also returned $100 million to shareholders in the quarter and declared another $0.50/share dividend. Management said synergies are ahead of schedule at $70 million of the $100 million target, tariff costs should stay below $15 million in 2025, and dayrates in high-end deepwater remain in the low-to-high $400,000s per day.

Analysis

Noble’s new backlog is not just bigger; it is qualitatively better because it extends visibility into 2027 while preserving pricing power through performance-linked economics. That matters for equity duration: the market has tended to value offshore drillers on spot dayrates and near-term utilization, but this quarter shifts the frame toward multi-year contracted cash generation with embedded upside, which should compress the perceived cyclicality discount. The likely second-order winner is the high-spec asset base, while older, lower-spec rigs and stacked units should face faster obsolescence and scrappage pressure as customers prioritize execution certainty and emissions-capable equipment.

The key signal for competitors is that Noble is effectively using scale and integration to reprice the top end of the market without conceding margin. If these structures start to spread, weaker operators may be forced either to accept lower guaranteed base rates or to spend more on upgrades, which tightens supply and raises the hurdle for reactivation. That creates a subtle but important mix shift: even with flat headline utilization, effective supply of premium rigs can remain tight enough to hold dayrates in the low-to-high $400k range.

The near-term risk is not demand collapse; it is timing risk. Q2 should look softer sequentially due to rollovers and downtime, which can invite traders to fade the name if they focus only on quarter-over-quarter EBITDA rather than the 2026-27 cash flow bridge. The bigger contrarian point is that the market may be underestimating how much of this backlog was signed after the April correction, implying customers are willing to commit through volatility and weakening the case that offshore is a purely lagging macro trade.

From a capital returns perspective, the dividend looks safer than the market likely assumes because the backlog already covers most of the year’s earnings bridge and capex is more clearly ring-fenced. The real sensitivity is tariffs and upgrade execution, but those appear manageable relative to the incremental contract value. If the bonus mechanisms deliver even modestly above management’s 40% assumption, the equity can rerate on both FCF and yield without requiring any oil price reacceleration.

Key Decisions for Investors

• Long NE common on pullbacks over the next 1-3 weeks; target 15-20% upside as the market digests the backlog inflection and dividend durability, with downside limited by contracted EBITDA visibility and yield support.
• Buy NE Jan-2026 call spreads to express the 2026-27 backlog re-rating; risk/reward favors options because Q2 may be seasonally softer even as the medium-term setup improves.
• Pair trade: long NE / short a lower-spec offshore driller or offshore services proxy over 3-6 months; thesis is premium-rig scarcity and integration-led margin durability versus weaker asset quality and more exposed spot leverage.
• Use any post-Q2 weakness to add to NE rather than chase strength; the setup is likely to be misread as a near-term earnings miss when it is actually a contract-duration upgrade story.
• If available, pair long NE against short an E&P name with higher direct oil beta to isolate the thesis that contracted offshore cash flows are becoming less correlated with spot crude over the next 12-24 months.